Successful Treatment of Chronic Hepatitis C using Pegylated Interferon and Ribavirin in a Patient with Sheehan's Syndrome
Journal Title: International Journal of Virology and AIDS - Year 2016, Vol 3, Issue 2
Abstract
A 50-year-old female with Sheehan's syndrome was treated for chronic hepatitis C using pegylated interferon-α2b and ribavirin. The patient's HCV-RNA status was negative by the fourth week and remained undetectable until the completion of treatment without signs that Sheehan's syndrome had been exaggerated. This case demonstrates that pegylated interferon-α2b and ribavirin does not necessarily exacerbate Sheehan's syndrome.
Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA
Background Correct measurements of residual viremia and reservoir size are crucial in HIV-1 eradication trials and there is a need for sensitive and automated assays. The increasing worldwide diversity of HIV-1 subtypes...
The Monitoring of Lymphocyte Populations may be Optional in Patients with Suppressed Viremia: A Two Years Observational Study
The determination of lymphocyte populations (LPs) traditionally has been included in the routine follow-up of HIV-infected patients as an indicator of the degree of immune suppression and of the need to start treatment,...
The AIDS Myth at 30
In 1985 the KGB and East Berlin's professor of Biology started the AIDS disinformation campaign by accusing the United States of America of having constructed and spread the AIDS agent in the course of biological weapons...
Determinants of Survival in HIV Patients: A Retrospective Study of Dilla University Hospital HIV Cohort
Introduction:Highly Active Antiretroviral Therapy (HAART) has remarkably improved the survival of Human Immunodeficiency Virus (HIV) patients though it is not sufficient alone to achieve better HIV related clinical outco...
Elimination of Mother-to-Child Transmission of HIV in Democratic Republic of Congo: Implementation of "Test &Treat" Approach at Primary Health Centers
Background: The "Test & Treat" approach, also called option B+, using combination antiretroviral treatment (cART) for prevention of mother-to-child transmission (PMTCT) has been very effective in controlled clinical tria...